Meridian Bioscience Projects Growth in Sales, Income for Fiscal 2011

The company expects net sales for its 2011 fiscal year to be in the range of $165 million to $170 million, representing an increase of between 14 percent and 17 percent over projected fiscal 2010 sales.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.